The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Chutko L.S.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg;
Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Anisimova T.I.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg;
Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Surushkina S.Yu.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg;
Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Aĭtbekov K.A.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg;
Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Attention deficit hyperactivity disorder: problems in a family and family therapy

Authors:

Chutko L.S., Anisimova T.I., Surushkina S.Yu., Aĭtbekov K.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(1): 89‑91

Read: 1482 times

Download PDF (RU)
Contact the author
Table of contents

ATTENTION DEFICIT HYPERACTIVITY DISORDER: PROBLEMS IN A FAMILY AND FAMILY THERAPY
ATTENTION DEFICIT HYPERACTIVITY DISORDER: PROBLEMS IN A FAMILY AND FAMILY THERAPY

To cite this article:

Chutko LS, Anisimova TI, Surushkina SYu, Aĭtbekov KA. Attention deficit hyperactivity disorder: problems in a family and family therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(1):89‑91. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Atte­ntion defi­cit diso­rder in adults: features of social and family rela­tionships. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(1):13-18
Abstract:

The results of an open prospective trial on the treatment of migraine with vasobral which was conducted in 170 medical centers (27 cities) of the Russian Federation are summarized. The trial included 5475 patients treated with vasobral in dosage 2 ml (1 ml contains 1 mg of alpha-dihydroergocryptine and 10 mg of caffeine) twice a day during 2 months. Assessment criteria of treatment efficacy were frequency and duration of migraine seizures, pain syndrome severity, presence of concomitant syndromes, general state and working capacity of patients and side-effects. Vasobral was effective and safe medication for the prevention of migraine. Its preventive effect is due to the decrease of frequency and duration of migraine seizures, pain severity and to the overall improvement of patient’s state. Vasobral can be recommended to many migraine patients, in particular to those in the young age and with short disease duration.

Keywords:

family
attention-deficit/hyperactivity disorder

Authors:

Chutko L.S.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg;
Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Anisimova T.I.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg;
Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Surushkina S.Yu.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg;
Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Aĭtbekov K.A.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg;
Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Close metadata

References:

  1. Mezhdunarodnaya klassifikatsiya golovnykh bolei. 2-e izd. (polnaya russkoyazychnaya versiya). M 2006;380.
  2. Tabeeva G.R., Azimova Yu.E. Profilakticheskoe lechenie migreni. M: IF-press 2009;84.
  3. Bussone G., Cerbo R., Martucci N. et al. Alpha-dihydroergocryptine in the prophylaxis of migraine: a multicenter double-blind study versus flunarizine. Headache 1999;39:426-431.
  4. Canonico P.L., Scapagnini U., Genazzani E., Zanotti A. Dihydroergocryptine (DEK) in the prophylaxis of common migraine: double-blind clinical study vs placebo. Cephalalgia 1989;9:Suppl 10:446-447.
  5. Closse A., Frick W., Dravid A. et al. Classification of drugs according to receptor binding profiles. Naunyn Schmiedebergs. Arch Pharmacol 1984;327:95-101.
  6. Diener H.C., Limmroth V. Advances in pharmacological treatment of migraine. Exp Opin Inv Drugs 2001;10:1831-1845.
  7. European principles of management of common headache disorders in primary care. (European Headache Federation and Lifting The Burden: The Global Campaign to Reduce the Burden of Headache Worldwide). J Headache Pain 2007;8:Suppl 1:1-42.
  8. Frediani F., Grazzi L., Zanotti A. et al. Dihydroergokryptine versus dihydroergotamine in migraine prophylaxis: a double-blind clinical trial. Cephalalgia 1991;11:117-121.
  9. Goadsby P.J., Schoenen J., Ferrari M.D. et al. Towards a definition of intractable headache for use in clinical practice and trials. Cephalalgia 2006;26:1168-1170.
  10. Micieli G., Cavallini A., Marcheselli S. et al. Alpha-dihydroergocryptine and predictive factors in migraine prophylaxis. Int J Clin Pharmacol Ther 2001;39:144-151.
  11. Schulman E.A., Peterlin B.L., Lake A.E. et al. Defining refractory migraine: results of the RHSIS survey of American headache society members. Headache 2009;49:509-518.
  12. Silberstein S.D. Preventive treatment of headaches. Curr Opin Neurol 2005;18:289-292.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.